longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Catheter Precision

VTAK

0.17506.06% ( +0.0100 )
Closed: Sep 11, 16:00:00 (EDT)
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.24, below the reasonable range, cheaper than 82.78% of the time in the past 3 years, and the industry ranks 58/175, the industry Median -0.96.

-0.244xP/E
$0.18Stock price
$-0.72Earnings per share
-0.244xP/E
Stock price$0.18Earnings per share$-0.72

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.14x
Typical range
-0.23x–-0.05x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.58x141.71%$12.30B
GKOSUSGlaukos
-52.46x75.34%$9.87B
TFXUSTeleflex
-5.38x118.39%$5.55B
PLSEUSPulse Biosciences
-47.32x27.55%$3.79B
IRTCUSIRhythm
-263.36x71.96%$3.67B
AXGNUSAxogen
-73.73x31.62%$2.47B
BFLYUSButterfly Network
-26.08x34.41%$1.95B
ASSTUSStrive
-1.96x63.26%$1.91B
NVCRUSNovocure
-12.16x2.52%$1.81B
ATECUSAlphatec
-14.86x41.67%$1.63B
KMTSUSKestra Medical Tech
-10.17x5.19%$1.34B
DRTSUSAlpha Tau Medical
-14.39x--$1.33B
AORTUSArtivion
-383.20x266.67%$1.22B
IARTUSIntegra LifeSciences
-166.57x109.50%$1.21B
TNDMUSTandem Diabetes
-18.80x77.82%$1.19B
PRCTUSPROCEPT BioRobotics
-10.63x3.47%$1.17B
ENOVUSEnovis
-1.01x100.97%$1.11B
CBLLUSCeribell
-13.74x35.15%$906.87M
SIBNUSSI-BONE
-56.30x8.85%$823.77M
AVRUSAnteris Tech Global
-7.86x53.33%$813.78M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.